Talking Precision Medicine
Talking Precision Medicine
Genialis
Zola-007: Giving T-cells the license to kill | Talking Precision Medicine #38
44 minutes Posted Aug 29, 2024 at 1:15 pm.
0:00
44:06
Download MP3
Show notes

What a pleasure to sit down with my long time colleague and friend, Art Krieg, to discuss his latest venture, Zola Therapeutics, and his adventures in the great outdoors. Art has launched and exited a number of innovative biotechs, each time delving deeper into mechanisms by which we can harness the immune system for therapeutic purposes. Join us as we discuss how — despite a well earned retirement — the siren song that led to Zola was strong enough to get Art back in the game. 


Episode 38 links: